Stock Market News
Ergomed appoints "expert" to enhance PrimeVigilance offering
Pharmaceutical services provider Ergomed announced on Friday a new hire has added specialist pharmacoepidemiology services to its PrimeVigilance drug safety and information offering.
The AIM-traded company said it had appointed Michael Forstner, the most recent owner and manager of Swiss-based consultancy Mesama Consulting, as head of risk management and pharmacoepidemiology.
Mesama's ongoing contracts will now be assigned to PrimeVigilance.
Stephen Stamp, Chief Executive Officer of Ergomed plc, said: "I am delighted to welcome Michael to Ergomed with his significant experience in PV services, in addition to his unique expertise in pharmacoepidemiology and risk management strategies."
Forstner is an "expertise" in pharmacovigilance (PV) stems from his experience in planning, developing, implementing and evaluating risk management studies for the safe use of medicinal products.
The company expects his appointment will build new revenue streams through the broadening of its premium service offering within PrimeVigilance.
"His appointment will add value to our PrimeVigilance services as well as providing a bridge between CRO and PV, which fits perfectly in our strategy to leverage our expertise in pharmacovigilance and late phase clinical research, and build a new revenue stream in both our PV and specialist CRO services. We remain focused on growing both of our service offerings organically and through strategic acquisitions," said Stamp.
As of 1028 BST, Ergomed's shares were up 3.49% at 237.00p.
The AIM-traded company said it had appointed Michael Forstner, the most recent owner and manager of Swiss-based consultancy Mesama Consulting, as head of risk management and pharmacoepidemiology.
Mesama's ongoing contracts will now be assigned to PrimeVigilance.
Stephen Stamp, Chief Executive Officer of Ergomed plc, said: "I am delighted to welcome Michael to Ergomed with his significant experience in PV services, in addition to his unique expertise in pharmacoepidemiology and risk management strategies."
Forstner is an "expertise" in pharmacovigilance (PV) stems from his experience in planning, developing, implementing and evaluating risk management studies for the safe use of medicinal products.
The company expects his appointment will build new revenue streams through the broadening of its premium service offering within PrimeVigilance.
"His appointment will add value to our PrimeVigilance services as well as providing a bridge between CRO and PV, which fits perfectly in our strategy to leverage our expertise in pharmacovigilance and late phase clinical research, and build a new revenue stream in both our PV and specialist CRO services. We remain focused on growing both of our service offerings organically and through strategic acquisitions," said Stamp.
As of 1028 BST, Ergomed's shares were up 3.49% at 237.00p.
Related share prices |
---|
Ergomed (ERGO) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price